Floatz logo

Therapeutic Asset Ratings

472 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
(+)-VINCRISTINE
Breast Cancer
PfizerP4BB (67)
ETOPOSIDE
Non-Small Cell Lung Cancer
PfizerP3BB (67)
Irinotecan
Intestinal Neoplasms
PfizerP3BB (67)
Rybelsus
Adolescent Obesity
PfizerP2/3BB (67)
Panobinostat
Non-Small Cell Lung Cancer
PfizerP4BB (66)
su011248
Clear Cell Renal Cell Carcinoma
PfizerP4BB (66)
Calaspargase Pegol
Carcinoma, Non-Small-Cell Lung (NSCLC)
PfizerP3BB (66)
Cetuximab
Head and Neck Cancer
PfizerP3BB (66)
Irinotecan
Digestive System Disease
PfizerP3BB (66)
pf-08634404
Advanced Non-Small Cell Lung Cancer
PfizerP3BB (66)
su011248
Kidney Neoplasms
PfizerP3BB (66)
(+)-VINCRISTINE
Non-Small Cell Lung Cancer
PfizerP3BB (66)
Itraconazole
Androgen-insensitive Prostate Cancer
PfizerP2BB (66)
Itraconazole
Castrate-resistant Prostate Cancer (CRPC)
PfizerP2BB (66)
Docetaxel
Non Small-cell Lung Cancer
PfizerP3BB (65)
Erwinia L-Asparaginase
Acute Lymphoblastic Leukemia
PfizerP3BB (65)
Irinotecan
Gastrointestinal Neoplasms
PfizerP3BB (65)
Cyclophosphamide
Colorectal Neoplasms
PfizerP3BB (64)
Cyclophosphamide
Lung Neoplasms
PfizerP3BB (64)
Eloxatin
Colorectal Adenocarcinoma
PfizerP3BB (64)
Eloxatin
Triple Negative Breast Cancer
PfizerP3BB (64)
Epirubicin
Colorectal Neoplasms
PfizerP3BB (64)
fx-1006a
Hereditary Transthyretin Amyloidosis (ATTRv)
PfizerP3BB (64)
Ivuxolimab
Advanced Malignancies
PfizerP3BB (64)
Eloxatin
Triple Negative Breast Neoplasms
PfizerP2BB (64)
Showing 26 to 50 of 472 assets
PreviousPage 2 of 19Next